首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination
【2h】

Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination

机译:禽冠状病毒感染性支气管炎减毒活疫苗在接种疫苗后经历亚群和突变的选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, we were interested in determining if high titered egg adapted modified live infectious bronchitis virus (IBV) vaccines contain spike gene related quasispecies that undergo selection in chickens, following vaccination. We sequenced the spike glycoprotein of 12 IBV vaccines (5 different serotypes from 3 different manufacturers) directly from the vaccine vial, then compared that sequence with reisolated viruses from vaccinated and contact-exposed birds over time. We found differences in the S1 sequence within the same vaccine serotype from different manufacturers, differences in S1 sequence between different vaccine serials from the same manufacturer, and intra-vaccine differences or quasispecies. Comparing the sequence data of the reisolated viruses with the original vaccine virus, we were able to identify selection of viral subpopulations as well as mutations. To our knowledge, this is the first report showing selection of a more fit virus subpopulation as well as mutations associated with replication of modified live IBV vaccine viruses in chickens. This information is important for our understanding of how attenuated virus vaccines, including potential vaccines against the SARS-CoV, can ensure long-term survival of the virus and can lead to changes in pathogenesis and emergence of new viral pathogens. This information is also valuable for the development of safer modified live coronavirus vaccines.
机译:在这项研究中,我们感兴趣的是确定适应高滴度卵的改良活感染性支气管炎病毒(IBV)疫苗是否含有与穗基因相关的准种,这些准种在接种疫苗后在鸡中进行选择。我们直接从疫苗瓶中测序了12种IBV疫苗的尖峰糖蛋白(来自3个不同制造商的5种不同血清型),然后将该序列与经过一段时间接种和接触禽鸟的分离病毒进行了比较。我们发现来自不同制造商的同一疫苗血清型内的S1序列存在差异,来自同一制造商的不同疫苗系列之间的S1序列之间存在差异,以及疫苗内差异或准种。将重新分离的病毒与原始疫苗病毒的序列数据进行比较,我们能够鉴定出病毒亚群的选择以及突变。据我们所知,这是第一份报告,显示了更适合的病毒亚群的选择以及与鸡中改良的活IBV疫苗病毒复制相关的突变。该信息对于我们理解减毒病毒疫苗(包括针对SARS-CoV的潜在疫苗)如何确保病毒的长期存活并导致发病机理的变化和新病毒病原体的出现非常重要。该信息对于开发更安全的改良型冠状病毒活疫苗也很有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号